IODS PIPE CLAD LIMITED

Company number SC071447 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: IODS PIPE CLAD LIMITED

1. Financial Health Score: D+

Explanation: The patient is in a chronic state of technical insolvency, having operated with negative net assets for at least five consecutive years. However, unlike many businesses in this condition, there are encouraging vital signs—profitability has returned, cash reserves have strengthened significantly, and the net liability position is steadily improving. The company is on a ventilator of sorts, sustained by group support and future contract pipelines, but the trajectory suggests a potential path to recovery rather than terminal decline.


2. Key Vital Signs

Heart Rate – Solvency Position

Year Ending Net Assets Trend
Mar 2020 (£1,731k) Baseline
Mar 2021 (£1,853k) Worsened
Mar 2022 (£3,143k) Significantly worsened
Mar 2023 (£3,697k) Worst position
Mar 2024 (£2,325k) Improving
Nov 2024 (£1,800k) Continued improvement

Interpretation: The patient's heart is beating, but weakly. Net liabilities peaked at nearly £3.7m in 2023 but have halved to £1.8m by November 2024. This is the financial equivalent of a patient who has been critically ill but is now showing signs of responding to treatment.

Blood Pressure – Liquidity

Metric Nov 2024 Mar 2024
Current Assets £1,607k £1,777k
Current Liabilities (£4,444k) (£4,115k)
Net Current Liabilities (£2,837k) (£2,338k)
Current Ratio 0.36:1 0.43:1

Interpretation: Dangerously low blood pressure. A healthy current ratio sits above 1.5:1; this company has only 36p of current assets for every £1 of current liabilities. The working capital position has actually deteriorated in the latest period, though this needs context—the accounting period was shortened to 8 months to align with the parent company's year-end.

Temperature – Cash Position

Year Ending Cash Trend
Mar 2020 £25k Critically low
Mar 2021 £694k Recovered
Mar 2022 £68k Relapsed
Mar 2023 £423k Improving
Mar 2024 £23k Concerning dip
Nov 2024 £905k Strong recovery

Interpretation: The patient's temperature has been volatile—feverish spikes followed by concerning drops. The latest reading of £905k is the healthiest cash position in the recorded history, suggesting improved cash management or timing of receipts.

Respiratory Rate – Profitability

Period Profit
Year to Mar 2024 £1,372k
8 months to Nov 2024 £525k

Interpretation: The patient is breathing. Annualised, the 8-month profit of £525k suggests approximately £788k for a full year—lower than the prior year but still positive. The company has moved from chronic losses to consistent profitability, which is the most encouraging vital sign.

Body Mass Index – Balance Sheet Composition

Category Nov 2024 % of Total
Non-current Assets £3,437k 68%
Current Assets £1,607k 32%
Total Assets £5,044k 100%
Current Liabilities (£4,444k) 74%
Non-current Liabilities (£2,266k) 38%
Provisions (£134k) 2%
Net Liabilities (£1,800k)

Interpretation: The balance sheet is heavily weighted toward liabilities, with current liabilities representing nearly three-quarters of total assets. The asset base is dominated by property, plant, and equipment (£2,817k), which provides operational capacity but limited liquidity.


3. Diagnosis

Primary Condition: Chronic Technical Insolvency with Improving Prognosis

The company has operated in a state of technical insolvency—where total liabilities exceed total assets—for at least five consecutive years. In medical terms, this is a chronic condition that has persisted for an extended period.

Contributing Factors Identified:

  1. Group Dependency: The company is sustained within a group structure, with Ftv Proclad International Limited and Glenalmond Group Ltd both holding more than 75% of shares and voting rights. Intercompany receivables of £620k exist within non-current assets, and the going concern assessment explicitly references group support and a frame agreement with a major customer routed through a fellow group company.

  2. Working Capital Strain: Net current liabilities of £2.8m create ongoing pressure. The company must manage cash carefully and likely relies on group financing facilities or intercompany support to bridge timing gaps between payments to suppliers and receipts from customers.

  3. Cyclical Vulnerability: As a manufacturer in the oil field supply sector (the original name was "International Oil Field Drilling Supplies Limited"), the business is exposed to commodity price cycles and project timing risks. The director acknowledges this in the going concern note, citing supply chain or customer delays as the primary risk.

  4. Accounting Period Change: The shift from a March year-end to November was made to align with the parent undertaking, suggesting closer group integration and oversight—which could be positive for governance but may also indicate the parent is taking a more hands-on approach to a subsidiary that has required sustained support.

Secondary Conditions

  • Heavy Fixed Asset Base: £2.8m in property, plant, and equipment represents significant capital tied up in operational assets. While necessary for manufacturing, this limits flexibility.
  • Inventory and Receivables Management: Inventories of £317k and trade receivables of £385k (current) plus £620k (non-current, likely intercompany) require careful management to convert to cash efficiently.

4. Recommendations

Immediate Treatment (0-6 months)

  1. Strengthen Working Capital: The net current liabilities of £2.8m represent the most acute symptom. Negotiate extended payment terms with suppliers where possible, accelerate collection of trade receivables, and consider whether inventory levels can be optimized without compromising delivery capability.

  2. Formalise Group Support: While the going concern note references group support and a frame agreement, ensure this support is formally documented and, where appropriate, guaranteed. Letters of comfort or formal undertakings from the parent provide greater certainty than informal assurances.

  3. Cash Flow Monitoring: Despite the improved cash position of £905k, the volatile history suggests this can deteriorate rapidly. Implement rolling 13-week cash flow forecasts with weekly review, and establish early warning triggers for when cash falls below defined thresholds.

Medium-Term Rehabilitation (6-18 months)

  1. Accelerate Debt Reduction: The company is generating profits—direct a meaningful portion toward reducing the net liability position. A target of reaching positive net assets within 3-4 years would be ambitious but achievable if current profitability is sustained.

  2. Diversify Revenue Streams: Dependency on a frame agreement with a major customer, while providing visibility, creates concentration risk. Work toward securing additional customers or contracts that reduce reliance on any single relationship.

  3. Review Asset Utilisation: With £2.8m in fixed assets, assess whether all property, plant, and equipment is being optimally utilised. Consider whether any assets could be sold and leased back, or whether underutilised assets could be disposed of to reduce liabilities.

Long-Term Wellness (18+ months)

  1. Target Solvency Milestone: Set a clear milestone for achieving positive net assets. Based on current trajectories, if the company can sustain profits of approximately £700k-£1m annually, the net liability position of £1.8m could be eliminated within 2-3 years.

  2. Strengthen Balance Sheet: Consider whether the parent group might inject equity or convert intercompany loans to equity, which would immediately improve the solvency position and provide a stronger foundation for future growth.

  3. Review Group Structure: Given the intercompany relationships and shared frame agreements, assess whether the current corporate structure is optimal, or whether consolidation or restructuring within the group might create efficiencies.


Prognosis

Cautiously Optimistic with Significant Caveats

The trend is the most encouraging aspect of this assessment. After reaching a nadir of £3.7m net liabilities in March 2023, the company has halved this position within 20 months while returning to profitability and building a substantial cash reserve. The "patient" is responding to treatment.

However, the chronic nature of the insolvency means the company remains vulnerable. If the frame agreement with the major customer does not materialise as expected, or if group support were withdrawn, the business would face acute distress. The director's going concern assessment is candid about these risks, which is itself a positive sign—recognition of the condition is the first step toward recovery.

The next 12-18 months are critical. If the current trajectory continues—profitability sustained, cash position maintained, net liabilities reduced—the company could return to a net asset position within 3-4 years. If external conditions deteriorate or the frame agreement fails to deliver expected volumes, the group may need to consider more radical interventions.


Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 10 August 2026